



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

1014






                                    ANSWERED ON: 
                                

07.02.2020






Snake Bite Deaths




T.N. Prathapan














                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) whether as per media reports India is considered as the high burden country in terms of snake bite death/ injury/disability and the policies and actions are not adequate in this regard, if so, the details thereof along with recent snake bite and injury/disability reported, State/ UT-wise;(b) the steps taken/proposed to address the issues related to reporting/non-reporting of the snake bite death/ injuries/disability and to implement the recent WHO’s global strategy for prevention and control of snake bite envenoming in India;(c) whether the Government is considering a national strategy of snake bite envenoming to control, prevent and address the India specific situation and if so, the details thereof;(d) whether the Government is aware of some studies on quality of the Anti-Snake Venom (ASV) and its effectiveness in mitigating snake bite and the WHO standards not being followed in ASV currently manufactured in India in terms of collection, storage, transport and purification and if so, the details thereof;(e) whether low price fixed for Indian ASV by DPCO is hampering its quality and putting lives in danger, if so, the details thereof; and(f) the measures taken/proposed to improve the manufacturing standard and quality of ASV that is representative of snake species all over the country?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a):	As per data available with Central Bureau of Health Intelligence (CBHI), under this Ministry the State/UT-wise details of cases and deaths reported due to snake bites, during the last three years in the country are given in annexure.(b) & (c):	Indian Council of Medical Research (ICMR) has constituted a “National Task Force for Research on Snake Bite in India” with the following national level multi-centric projects:I.	Nationwide Study to estimate incidence, mortality, morbidity and economic burden due to snakebite in IndiaII.	ICMR National Snakebite Project (INSP) on capacity building of health system on prevention and management of snakebite envenomation including its complications.Ministry of Health and Family Welfare has also issued directions to all the States/UTs to includes Anti Snake Venom Serum (ASVS) in the list of essential drugs of the State, procure these drugs locally for supply to Health Facilities for use to the needy persons and support the same under National Health Mission.(d):	As per information available in public domain, one study has indicated that currently marketed anti-venoms were found to exhibit poor dose efficacy and venom recognition potential against the venom of neglected snake species while the marketed anti-venom formulations are meant for the commonly found four snake species. The snake venom antiserum is required to be manufactured in India as per the provision of the Drugs and Cosmetic Act, 1940 and rules framed thereunder. (e) & (f):	The drug manufacturers in the Country are required to comply with the standards laid down in the Indian Pharmacopoeia and the provisions of the Drugs & Cosmetics Act, 1940. As per the rules framed under the Drugs & Cosmetics Act, 1940, the applicants of drug manufacturing units have to mandatorily submit evidence of stability, safety of excipients, etc. to the State Licencing Authority. Government have taken measures to ensure quality of the Drug, such as, amendment in the Drugs and Cosmetics Act, 1940 to provide stringent penalties for manufacture of spurious and adulterated drugs including making some offences cognizable and non-bailable, the testing capacities of Central Drugs Testing Laboratories under Central Drugs Standard Control Organization (CDSCO) are strengthened to expedite testing of drug samples in the country, joint pre-inspection of manufacturing units before grant of licence, joint inspection of manufacturing units to ensure compliance with the conditions of license and the provisions of the Drugs & Cosmetics Act and rules as per risk based approach, etc. 
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113173810







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







